Physician
Thomas Mark Johnson, M.D.
According to 2025 Medicare claims, Thomas Johnson, M.D. (NPI: 1366498545) practices ophthalmology in the Frederick-Gaithersburg-Bethesda, MD market, with the plurality of this provider's patient population coming from Montgomery, MD. This provider's primary affiliated billing organization is THE RETINA GROUP OF WASHINGTON, PLLC (NPI: 1225001654; TIN: 521570295) and primary practice location at 20852-1197. Johnson is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171) and Vytalize Health 9 ACO LLC (ACO ID: D0313), participating under the REACH model.
Johnson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,661 traditional Medicare patients, billed 42,029 HCPCS/CPT codes, and received $3,987,706 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 624 prescription claims across 190 beneficiaries totaling $51,041 in drug costs, led by Cyclosporine (Cyclosporine). Open Payments data shows 16 records totaling $518. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $52,081 and ending at $51,041. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.